The stock market once again experienced a poor show with stocks dropping with the shareholders' poise in the wearying revival of the economy remaining uninfluenced by the rising expenditure by customers and the spell of takeovers and unions.

Financers are of the opinion that the spending on the part of consumers has increased in months of July and in August but it is not certain that this continue in the comings months too keeping in mind the dearth of improvement in the unemployment aspect which makes this trend unmaintainable.

While Standard & Poor's index dropped by 0.11 5, the index of Dow Jones industries also saw a deterioration by 0.17%.

On the other hand while Intel Corporation agreed to purchase the subsidiary of Infineon Technologies Ag, a German based chip manufacturer at the price of $1.4 billion, Genzyme, the US based biotechnology firm, moved over its quietness for weeks over the $18.5 billion acquisition proposal made by Sanofi Aventis as it declined the offer straight forward and leading to a rise in the shares of Sanofi by 0.5 %.